Oncology and hematology

腫瘍・血液内科について

最新年度業績

2023年

  1. Yamamoto K, Kawamoto S, Chijiki R, Watanabe M, Matsumoto S, Kitao A, Mizutani Y, Kajimoto K, Hayashi Y, Yakushijin K, Minami H. Biclonal diffuse large B-cell lymphoma commonly characterized by partial trisomy 18q involving MALT1 and BCL2.Intern Med 2023 Jan 15;62(2):285-292. doi: 10.2169/internalmedicine.9711-22. Epub 2022 Jun 14.


    https://pubmed.ncbi.nlm.nih.gov/35705274/

  2. Mizutani Y, Kawamoto S, Takahashi N, Doi H, Wakida K, Tabuchi S, Tanda M, Soga A, Chijiki R, Takakura H, Kawaguchi K, Higashime A, Watanabe M, Ichikawa H, Matsumoto S, Sakai R, Goto H, Kurata K, Kakiuchi S, Miyata Y, Uryu K, Inui Y, Kitao A, Yakushijin K, Matsuoka H, Minami H. Efficacy and safety of synbiotics in patients undergoing autologous hematopoietic stem cell transplantation: A prospective, randomized, double-blind, placebo-controlled pilot study. Intern Med 2023 Oct 15;62(20):2949-2958. doi: 10.2169/internalmedicine.1314-22. Epub 2023 Feb 15.


    https://pubmed.ncbi.nlm.nih.gov/36792187/

  3. Nishikubo M, Tanaka Y, Mitsui S, Doi T, Hokka D, Hojo W, Sakai H, Funakoshi Y, Yakushijin K, Ohji G, Minami H, Maniwa Y.Comparable efficacy and safety of COVID-19 vaccines for patients receiving tegafur-uracil as postoperative adjuvant chemotherapy.Surg Today.2023 Sep;53(9):1057-1063. doi: 10.1007/s00595-023-02649-1. Epub 2023 Feb 8.


    https://pubmed.ncbi.nlm.nih.gov/36752867/

  4. Yamamoto K, Matsumoto H, Matsumoto S, Sakai R, Kitao A, Watanabe M, Goto H, Sugimoto T, Yano Y, Yakushijin K, Minami H. Unexpected appearance of KMT2A::MLLT10 fusion transcript in acute myeloid leukemia with t(5;11)(q31;q23.3) Cancer Genet. 2023 Apr:272-273:41-46. doi: 10.1016/j.cancergen.2023.02.002. Epub 2023 Feb 4.


    https://pubmed.ncbi.nlm.nih.gov/36774707/

  5. Ishiki H, Kikawa Y, Terada M, Mizusawa J, Honda M, Iwatani T, Mizutani T, Mori K, Nakamura N, Miyaji T, Yamaguchi T, Ando M, Patient-reported outcome and quality of life research policy: Japan Clinical Oncology Group (JCOG) policy.Jpn J Clin Oncol. 2023 Mar 7;53(3):195-202. doi: 10.1093/jjco/hyad007.


    https://pubmed.ncbi.nlm.nih.gov/36702740/

  6. Fujita Y, Kamitani F, Yamamoto M, Fukuoka H, Hirota Y, Nishiyama N, Goda N, Okada Y, Inaba Y, Nakajima H, Kurematsu Y, Kanie K, Combined Hypophysitis and Type 1 Diabetes Mellitus Related to Immune Checkpoint Inhibitors.J Endocr Soc. 2023 Jan 6;7(3):bvad002. doi: 10.1210/jendso/bvad002.


    https://pubmed.ncbi.nlm.nih.gov/36694808/

  7. Okamoto S, Urade T, Yakushijin K, Kido M, Kuramitsu K, Komatsu S, Gon H, Yamashita H, Shirakawa S, Tsugawa D, Terai S, Yanagimoto H, Toyama H, Fukumoto T. Successful Management of Refractory Autoimmune Hemolytic Anemia with Cold Agglutinin Disease with Splenectomy: A Case Report with Review of Literature.Kobe J Med Sci. 2023 Jan 11;68(1):E30-E34


    https://pubmed.ncbi.nlm.nih.gov/36647084/

  8. Rai S, Kim WS, Ando K, Choi I, Izutsu K, Tsukamoto N, Yokoyama M, Tsukasaki K, Kuroda J, Ando J, Hidaka M, Koh Y, Shibayama H, Uchida T, Yang DH, Ishitsuka K, Ishizawa K, Kim JS, Lee HG, Minami H, Eom HS, Kurosawa M, Lee JH, Oral HDAC inhibitor tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: phase IIb results.Haematologica. 2023 Mar 1;108(3):811-821. doi: 10.3324/haematol.2022.280996.


    https://pubmed.ncbi.nlm.nih.gov/36200417/

  9. Nagao S, Yakushijin K, Higashime A, Kawaguchi K, Watanabe M, Sakai R, Ichikawa H, Mizutani Y, Goto H, Kakiuchi S, Kurata K, Kitao A, Miyata Y, Imamura Y, Hirota Y, Takahashi M, Kawamoto S, Yamamoto K, Matsuoka H, Minami H. Safety and Accuracy of Professional Continuous Glucose Monitoring in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.Blood Cell Ther. 2023 Mar 24;6(2):54-60. doi: 10.31547/bct-2022-024. eCollection 2023 May 25.


    https://pubmed.ncbi.nlm.nih.gov/37342353/

  10. Mauro MJ, Hughes TP, Kim DW, Réa D, Cortes JE, Hochhaus A, Sasaki K, Breccia M, Talpaz M, Ottmann O, Minami H, Goh YT, DeAngelo DJ, Heinrich MC, Gomez Garcia de Soria V, Le Coutre P, Mahon FX, Janssen JJWM, Deininger M, Shanmuganathan N, Geyer MG, Cacciatore S, Polydoros F, Agrawal N, Hoch M, Lang F. Asciminib monotherapy in patients with CML-CP without BCR::ABL1 T315I mutations treated with at least two prior TKIs: 4-year phase 1 safety and efficacy results.Leukemia. 2023 May;37(5):1048-1059. doi: 10.1038/s41375-023-01860-w. Epub 2023 Mar 22.


    https://pubmed.ncbi.nlm.nih.gov/36949155/

  11. Hirakawa Y, Kitao A, Watanabe M, Matsumoto S, Komaki R, Sakai R, Morimono K, Yakushijin K, Minami H. Irreversible Intrathecal Chemotherapy-induced Myelopathy in a Patient with Diffuse Large B-cell Lymphoma.Intern Med. 2024 Feb 15;63(4):547-551. doi: 10.2169/internalmedicine.2031-23. Epub 2023 Jun 28.


    https://pubmed.ncbi.nlm.nih.gov/37380452/

  12. Ichikawa H, Yakushijin K, Miyata Y, Kanehira H, Joyce M, Hirakawa Y, Matsumoto S, Nagao S, Sakai R1, Kurata K, Kitao A, Saito Y, Kawamoto S, Yamamoto K, Ito M, Murayama T, Matsuoka H, Minami H. Early diagnosis of sinusoidal obstruction syndrome after hematopoietic stem cell transplantation, with modified diagnostic criteria including refractory thrombocytopenia.EJHaem. 2023 Jun 1;4(3):695-704. doi: 10.1002/jha2.728. eCollection 2023 Aug.


    https://pubmed.ncbi.nlm.nih.gov/37601886/

  13. Shimura Y, Komatsu S, Nagatani Y, Funakoshi Y, Sofue K, Kido M, Kuramitsu K, Gon H, Fukushima K, Urade T, So S, Yanagimoto H, Toyama H, Minami H, Fukumoto T The Usefulness of Total Tumor Volume as a Prognostic Factor and in Selecting the Optimal Treatment Strategy of Chemotherapeutic Intervention in Patients with Colorectal Liver Metastases.Ann Surg Oncol. 2023 Oct;30(11):6603-6610. doi: 10.1245/s10434-023-13746-3. Epub 2023 Jun 29


    https://pubmed.ncbi.nlm.nih.gov/37386304/

  14. Shimura Y, Komatsu S, Minami H, Fukumoto T. ASO Author Reflections: Can the Total Tumor Volume be an Indicator for Optimal Treatment Strategy in Patients with Colorectal Liver Metastases?Ann Surg Oncol. 2023 Oct;30(11):6611-6612. doi: 10.1245/s10434-023-13870-0. Epub 2023 Jul 20.


    https://pubmed.ncbi.nlm.nih.gov/37474694/

  15. Shimura Y, Komatsu S, Nagatani Y, Funakoshi Y, Sofue K, Kido M, Kuramitsu K, Gon H, Fukushima K, Urade T, So S, Yanagimoto H, Toyama H, Minami H, Fukumoto T. The Usefulness of Total Tumor Volume as a Prognostic Factor and in Selecting the Optimal Treatment Strategy of Chemotherapeutic Intervention in Patients with Colorectal Liver Metastases.Ann Surg Oncol. 2023 Oct;30(11):6603-6610. doi: 10.1245/s10434-023-13746-3. Epub 2023 Jun 29.


    https://pubmed.ncbi.nlm.nih.gov/37386304/

  16. Kawamoto S, Shinkawa E, Fujiwara S, Oda Y, Jimbo H, Nakano E, Fujumoto T, Ono R, Yasuda T, Minami H. Treatment of dermal ulcer with autologous fibrin glue: Two case reports of an exploratory prospective pilot study.Medicine (Baltimore). 2023 Nov 17;102(46):e36134. doi: 10.1097/MD.0000000000036134.


    https://pubmed.ncbi.nlm.nih.gov/37986310/

  17. Yamamoto K, Kitao A, Watanabe M, Kanehira H, Joyce M, Hirakawa Y, Matsumoto S, Yakushijin K, Minami H. RUNX1 rearrangement in mature B-cell acute lymphoblastic leukemia with non-L3 morphology.J Clin Exp Hematop. 2023 Dec 26;63(4):240-245. doi: 10.3960/jslrt.23028. Epub 2023 Oct 28.


    https://pubmed.ncbi.nlm.nih.gov/37899239/

  18. Shimoyama R, Imamura Y, Uryu K, Mase T, Fujimura Y, Hayashi M, Ohtaki M, Otani K, Shinozaki N, Minami H. Real‑world treatment outcomes among patients with metastatic pancreatic cancer in Japan: The Tokushukai real‑world data project.Mol Clin Oncol. 2023 Oct 25;19(6):98. doi: 10.3892/mco.2023.2694. eCollection 2023 Dec.


    https://pubmed.ncbi.nlm.nih.gov/37953858/

  19. Kintsu M, Odajima S, Takeuchi K, Ichikawa Y, Todo S, Ota E, Yamauchi Y, Shiraki H, Yamashita K, Fukuda T, Hisamatsu E, Minami H, Hirata K. Effect of increase in heart rate after anthracycline chemotherapy on subsequent left ventricular dysfunction.J Cardiol. 2024 Aug;84(2):119-125. doi: 10.1016/j.jjcc.2023.11.001. Epub 2023 Nov 9.


    https://pubmed.ncbi.nlm.nih.gov/37949314/

  20. Saito Y, Iida-Norita R, Afroj T, Refaat A, Hazama D, Komori S, Ohata S, Takai T, Oduori O, Kotani T, Funakoshi Y, Koma Y, Murata Y, Yakushijin K, Matsuoka H, Minami H, Yokozaki H, Manz MG, Matozaki T. Preclinical evaluation of the efficacy of an antibody to human SIRPα for cancer immunotherapy in humanized mouse models.Front Immunol. 2023 Dec 14:14:1294814. doi: 10.3389/fimmu.2023.1294814. eCollection 2023.


    https://pubmed.ncbi.nlm.nih.gov/38162643/

  21. Yanagisawa R, Koyama H, Yakushijin K, Uchida N, Jinguji A, Takeda W, Nishida T, Tanaka M, Eto T, Ohigashi H, Ikegame K, Matsuoka KI, Katayama Y, Kanda Y, Sawa M, Kawakita T, Onizuka M, Fukuda T, Atsuta Y, Shinohara A, Nakasone H. Analysis of risk factors for fatal renal complications after allogeneic hematopoietic cell transplantation.Bone Marrow Transplant. 2024 Mar;59(3):325-333. doi: 10.1038/s41409-023-02172-4. Epub 2023 Dec 16.


    https://pubmed.ncbi.nlm.nih.gov/38104219/

  22. Yamamoto K, Kitao A, Watanabe M, Kanehira H, Joyce M, Hirakawa Y, Matsumoto S, Yakushijin K, Minami H. RUNX1 rearrangement in mature B-cell acute lymphoblastic leukemia with non-L3 morphology.J Clin Exp Hematop. 2023 Dec 26;63(4):240-245. doi: 10.3960/jslrt.23028. Epub 2023 Oct 28.


    https://pubmed.ncbi.nlm.nih.gov/37899239/

  23. Kuroda R, Niikura T, Matsumoto T, Fukui T, Oe K, Mifune Y, Minami H, Matsuoka H, Yakushijin K, Miyata Y, Kawamoto S, Kagimura T, Fujita Y, Kawamoto A. Phase III clinical trial of autologous CD34 + cell transplantation to accelerate fracture nonunion repair.BMC Med. 2023 Oct 5;21(1):386. doi: 10.1186/s12916-023-03088-y.


    https://pubmed.ncbi.nlm.nih.gov/37798633/

  24. Funakoshi Y, Yakushijin K, Ohji G, Matsutani T, Hojo W, Sakai H, Matsumoto S, Watanabe M, Kitao A, Saito Y, Kawamoto S, Yamamoto K, Koyama T, Nagatani Y, Kimbara S, Imamura Y, Kiyota N, Ito M, Minami H. Response to mRNA SARS-CoV-2 vaccination evaluated by B-cell receptor repertoire after tixagevimab/cilgavimab administration.Br J Haematol. 2023 Aug;202(3):504-516. doi: 10.1111/bjh.18932. Epub 2023 Jun 22.


    https://pubmed.ncbi.nlm.nih.gov/37349876/

  25. Tamaki M, Akahoshi Y, Okada Y, Uchida N, Tanaka M, Doki N, Sawa M, Maruyama Y, Ueda Y, Miyakoshi S, Katayama Y, Kawakita T, Kimura T, Onizuka M, Fukuda T, Atsuta Y, Yanagisawa R, Yakushijin K, Kanda J, Nakasone H. Unrelated female-to-male bone marrow transplantation would be preferred over cord blood transplantation in male patients.Cytotherapy. 2023 Nov;25(11):1220-1228. doi: 10.1016/j.jcyt.2023.06.002. Epub 2023 Jun 20.


    https://pubmed.ncbi.nlm.nih.gov/37349876/

  26. Tamaki M, Akahoshi Y, Ashizawa M, Misaki Y, Koi S, Kim SW, Ozawa Y, Fujiwara SI, Kako S, Matsuoka KI, Sawa M, Katayama Y, Onizuka M, Kanda Y, Fukuda T, Atsuta Y, Yakushijin K, Nakasone H. Impact of anti-thymocyte globulin on survival outcomes in female-to-male allogeneic hematopoietic stem cell transplantation.Sci Rep. 2023 May 3;13(1):7166. doi: 10.1038/s41598-023-34442-y.


    https://pubmed.ncbi.nlm.nih.gov/37138004/

    27. 2024年

    1. Shimoyama R, Imamura Y, Uryu K, Mase T, Fujimura Y, Hayashi M, Ohtaki M, Otani K, Shinozaki N, Minami H. Real‑world treatment outcomes among patients with metastatic pancreatic cancer in Japan: The Tokushukai real‑world data project.Mol Clin Oncol. 2023 Oct 25;19(6):98. doi: 10.3892/mco.2023.2694. eCollection 2023 Dec.


      https://pubmed.ncbi.nlm.nih.gov/37953858/

    2. Shimoyama R, Imamura Y, Uryu K, Mase T, Taguri M, Okuda T, Fujimura Y, Hayashi M, Tanaka S, Sawamukai K, Minami H. Real-world treatment outcomes of metastatic biliary tract cancer patients in Japan: the Tokushukai REAl-world data project 04 (TREAD 04).Jpn J Clin Oncol. 2024 Jan 7;54(1):70-80. doi: 10.1093/jjco/hyad133.


      https://pubmed.ncbi.nlm.nih.gov/37801431/

    3. Uryu K, Imamura Y, Shimoyama R, Mase T, Fujimura Y, Hayashi M, Ohtaki M, Otani K, Hibino M, Horiuchi S, Fukui T, Fukai R, Chihara Y, Iwase A, Yamada N, Tamura Y, Harada H, Shinozaki N, Tsuya A, Fukuoka M, Minami H. Stepwise prolongation of overall survival from first to third generation EGFR-TKIs for EGFR mutation-positive non-small-cell lung cancer: the Tokushukai REAl-world Data project (TREAD 01).Jpn J Clin Oncol. 2024 Mar 9;54(3):319-328. doi: 10.1093/jjco/hyad162.


      https://pubmed.ncbi.nlm.nih.gov/37997468/

    4. Kitahiro Y, Yamamoto K, Yakushijin K, Ioroi T, Tanda M, Itohara K, Omura T, Minami H, Yano I. The Efficacy of Bepotastine Besilate Compared With Hydroxyzine Pamoate for Preventing Infusion Reactions to the First Dose of Rituximab in Patients With Non-Hodgkin Lymphoma: Protocol for a Phase II, Double-Blind, Multicenter Randomized Trial.JMIR Res Protoc . 2024 Feb 22:13:e54882. doi: 10.2196/54882.


      https://pubmed.ncbi.nlm.nih.gov/38386393/

    5. Ichikawa H, Yakushijin K, Kurata K, Tsuji T, Takemoto N, Joyce M, Okazoe Y, Takahashi R, Matsumoto S, Sakai R, Kitao A, Miyata Y, Saito Y, Kawamoto S, Yamamoto K, Ito M, Murayama T, Matsuoka H, Minami H. Utility of the refined EBMT diagnostic and severity criteria 2023 for sinusoidal obstruction syndrome/veno-occlusive disease. Bone Marrow Transplant. 2024 Apr;59(4):518-525. doi: 10.1038/s41409-024-02215-4. Epub 2024 Jan 29.


      https://pubmed.ncbi.nlm.nih.gov/38287083/

    6. Onozawa M, Kusumoto S, Najima Y, Hashimoto H, Okada K, Tamaki M, Tanaka M, Sato T, Takahashi T, Hatano K, Onodera K, Moriuchi Y, Yakushijin K, Kanda J, Nagafuji K, Ogata M, Nakano N, Tamori A, Mizokami M. Outcomes of Cessation of Nucleos(t)ide Analog Administration on Hepatitis B Virus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Retrospective Study.Transplant Cell Ther. 2024 Mar;30(3):330.e1-330.e8. doi: 10.1016/j.jtct.2024.01.059. Epub 2024 Jan 17.


      https://pubmed.ncbi.nlm.nih.gov/38242442/

    7. Fuji S, Sugita J, Najima Y, Konishi T, Tanaka T, Ohigashi H, Eto T, Nagafuji K, Hiramoto N, Matsuoka KI, Maruyama Y, Ota S, Ishikawa J, Kawakita T, Akasaka T, Kamimura T, Hino M, Fukuda T, Atsuta Y, Yakushijin K. Low- versus standard-dose post-transplant cyclophosphamide as GVHD prophylaxis for haploidentical transplantation.Br J Haematol. 2024 Mar;204(3):959-966. doi: 10.1111/bjh.19228. Epub 2023 Nov 30.


      https://pubmed.ncbi.nlm.nih.gov/38037468/

    8. Okada Y, Usui Y, Hayashi H, Nishikubo M, Toubai T, Uchida N, Tanaka M, Onizuka M, Takahashi S, Doki N, Uehara Y, Maruyama Y, Ishiwata K, Kawakita T, Sawa M, Eto T, Ishimaru F, Kato K, Fukuda T, Atsuta Y, Kanda J, Yakushijin K, Nakasone H. Development of an umbilical cord blood transplantation-specific nonrelapse mortality risk assessment score.Blood Adv. 2024 Mar 26;8(6):1359-1368. doi: 10.1182/bloodadvances.2023011837.


      https://pubmed.ncbi.nlm.nih.gov/38163321/

    9. Nishikage S, Fujisawa A, Endoh H, Sakamoto H, Suzuki T, Kanzawa M, Ishii S, Okano M, Nitta E, Yakushijin K, Asakura H, Nozu K, Nitta R, Katayama Y, Sakaguchi K. Amyloid deposition through endocytosis in vascular endothelial cells.Exp Hematol. 2024 Jan:129:104129. doi: 10.1016/j.exphem.2023.11.003. Epub 2023 Nov 10.


      https://pubmed.ncbi.nlm.nih.gov/37952890/